References
Stone NJ, Robinson JG, Lichtenstein AH et al (2014) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 129:S1–S45
Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr et al (2004) Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 110:227–239
Reiner Z, Catapano AL, De Backer G et al (2011) ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 32:1769–1818
Yeaw J, Benner JS, Walt JG, Sian S, Smith DB (2009) Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm 15(9):728–740
Lars Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487–497
Nieuwkerk PT, Nierman MC, Vissers MN, Locadia M et al (2012) Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk. Am J Cardiol 110:666–672
Haynes RB, McDonald H, Garg AX, Montague P (2002) Interventions for helping patients to follow prescriptions for medications. Cochrane Database of Syst Rev. (2):CD000011. doi:10.1002/14651858.CD000011
Degli Esposti L, Saragoni S, Batacchi P, Benemei S et al (2012) Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis. Clin Ther 34:190–199
Ridker PM, Cook NR (2013) Statins: new American guidelines for prevention of cardiovascular disease. Lancet 382:1762–1765
Kavousi M, Leening MJG, Nanchen D, Greenland P et al (2014) Comparison of application of the ACC/AHA guidelines, adult treatment panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA 311(14):1416–1423
Kausik KR, Kastelein JJP, Boekholdt SM, Nicholls SJ et al (2014) The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011. Eur Heart J 35:960–968
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zambon, A. The new ACC/AHA guidelines on the treatment of dyslipidemia: cons. Intern Emerg Med 10, 119–122 (2015). https://doi.org/10.1007/s11739-014-1165-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-014-1165-5